The antiemetic efficacy of tropisetron plus dexamethasone as compared with conventional metoclopramide-dexamethasone combination in Orientals receiving cisplatin chemotherapy: A randomized crossover trial

British Journal of Clinical Pharmacology

Volumn 41, Issue 5, 1996, Pages 403-408

  Chua, D T T ^a,b   Sham, J S T ^a   Au, G K H ^a   Choy, D ^a   Kwong, D L W ^a   Yau, C C ^a   Cheng, A C K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Antiemesis; Chinese; Cisplatin; Dexamethasone; Metoclopramide; Tropisetron

Indexed keywords

CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; EPIRUBICIN; FLUOROURACIL; METOCLOPRAMIDE; MITOXANTRONE; TROPISETRON;

ADULT; ARTICLE; CHINA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NASOPHARYNX CARCINOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VERTIGO; VOMITING;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CISPLATIN; CROSS-OVER STUDIES; DEXAMETHASONE; DIPHENHYDRAMINE; DRUG THERAPY, COMBINATION; FEMALE; HONG KONG; HUMANS; INDOLES; MALE; METOCLOPRAMIDE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; SINGLE-BLIND METHOD; VOMITING;

EID: 0029980317     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.03268.x     Document Type: Article

References (14)

1. Saito H, Shimokata K, Yamori S, et al. Continuous infusion versus intermittent short infusion of metoclopramide for cisplatin-induced acute emesis. Am J Clin Oncol 1994; 17: 422-426.
2. Mori K, Saito Y, Tominaga K. Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis. Am J Clin Oncol 1993; 16: 338-341.
3. Strum SB, McDermed JE, Liponi DF. High-dose intravenous dexamethasone versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy. J Clin Oncol 1985; 3: 245-251.
4. 3 receptor antagonists the same? Eur J Cancer 1992; 28A (Suppl 1): s2-6.
5. Kutz K. Pharmacology, toxicology and human pharmacokinetics of tropisetron. Ann Oncol (Netherlands) 1993; 4 (Suppl 3): s15-18.
6. Sorbe B. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. Ann Oncol (Netherlands) 1993; 4 (Suppl 3): s39-42.
7. Bruntsch U, Dreschsler S, Eggert J, et al. Prevention of chemotherapy-induced nausea and vomiting by tropisetron alone or in combination with other antiemetic agents. Semin Oncol 1994; 21 (Suppl 9): 7-11.
8. Schmidt M, Sorbe B, Hogberg T, et al. Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin. Ann Oncol (Netherlands) 1993; 4 (Suppl 3): s31-34.
9. Hulstaret F, Van Belle S, Bleiberg H, et al. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting. J Clin Oncol 1994; 12: 2439-2446.
10. Gandara DR, Harvey WH, Monaghan GG, et al. The delayed-emesis syndrome from cisplatin : phase III evaluation of ondansetron versus placebo. Semin Oncol 1992; 19 (Suppl 10): s67-71.
11. Kris MG, Gralla RJ, Clark RA, et al. Incidence, course and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 1985; 3: 1379-1384.
12. Roila F, Boschetti E, Tonato M, et al. Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study. Am J Clin Oncol 1991; 14: 238-242.
13. Kris MG, Gralla RJ, Tyson LB, et al. Controlling delayed vomiting: double blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 1989; 7: 108-114.
14. Brutsch U, Rufenacht E, Parker I, et al. Tropisetron in the prevention of chemotherapy induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy. Ann Oncol (Netherlands) 1993; 4 (Suppl 3): s25-29.